Office of the Secretary; Amended Notice of Meeting, 63666 [2019-24849]

Download as PDF 63666 Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Secretary; Amended Notice of Meeting Notice is hereby given of a change in the Interagency Pain Research Coordinating Committee meeting on November 18, 2019, 08:30 a.m. to 05:00 p.m., Building 35A, Porter Neuroscience Center, Room 610, 35 Convent Drive, Bethesda, MD 20892, which was published in the Federal Register on October 18, 2019, 84 FR 55974. The meeting notice is amended to change the meeting agenda from the meeting will include discussions of committee business items including information about the NIH HEAL Initiative and an update on the Pain Management Best Practices Interagency Task Force to The meeting will include discussions of committee business items including the SUPPORT act, an update on the NIH HEAL Initiative and pain initiatives outside of the NIH. The meeting is open to the public. Dated: November 12, 2019. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–24849 Filed 11–15–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI SPORE (P50) I Review. Date: January 23–24, 2020. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. VerDate Sep<11>2014 17:41 Nov 15, 2019 Jkt 250001 Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Klaus B. Piontek, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, 9609 Medical Center Drive, Room 7W116, National Cancer Institute, Rockville, MD 20892–9750, 240–276–5413, klaus.piontek@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI SPORE (P50) II Review. Date: January 28–29, 2020. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Majed M. Hamawy, Ph.D., MBA, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Dr. Rm 7W120, Bethesda, MD 20892, 240–276–6457, mh101v@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI SPORE IV (P50) Review. Date: February 4–5, 2020. Time: 3:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: John Paul Cairns, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, 9609 Medical Center Drive, Room 7W244, National Cancer Institute, NIH, Bethesda, MD 20892, 240–276–5415 paul.cairns@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Feasibility and Planning Studies for SPOREs to Investigate Cancer Health Disparities (P20). Date: February 7, 2020. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, Rm 2W910/912, Rockville, MD 20850. Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review Officer, National Cancer Institute, NIH, Division of Extramural Activities, Research Programs Review Branch, 9609 Medical Center Dr., Rm 7W126, Bethesda, MD 20892–9750, 240–276–6348, lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–7A: SBIR Contract Review. Date: February 11, 2020. Time: 10:30 a.m. to 5:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, 6W030, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Ivan Ding, M.D. Health Scientist Administrator, National Cancer Institute, NIH, Division of Extramural Activities, Program & Review Extramural Staff Training Office, 9609 Medical Center PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 Dr., Room 7W534, Bethesda, MD 20892– 9750, 240–276–6444, dingi@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–7B: SBIR Contract Review. Date: February 12, 2020. Time: 10:30 a.m. to 4:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, 7W034, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Ivan Ding, M.D., Health Scientist Administrator, National Cancer Institute, NIH, Division of Extramural Activities, Program & Review Extramural Staff Training Office, 9609 Medical Center Dr., Room 7W534, Bethesda, MD 20892– 9750, 240–276–6444 dingi@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Program Project (P01) Review II. Date: February 13–14, 2020. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, Montgomery County Conference Center Facility, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Mukesh Kumar, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, 9609 Medical Center Drive, Room 7W618, National Cancer Institute, NIH Rockville, MD 20850, 240–276–6611 mukesh.kumar3@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–7C: SBIR Contract Review. Date: February 13, 2020. Time: 10:30 a.m. to 4:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Cancer Institute Shady Grove, 9609 Medical Center Drive, 7W030, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Ivan Ding, M.D., Health Scientist Administrator, National Cancer Institute, NIH, Division of Extramural Activities, Program & Review Extramural Staff Training Office, 9609 Medical Center Dr., Room 7W534, Bethesda, MD 20892– 9750, 240–276–6444, dingi@mail.nih.gov. Name of Committee: National Cancer Institute Initial Review Group; Subcommittee J—Career Development. Date: March 5–6, 2020. Time: 4:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Tushar Deb, Ph.D., Scientific Review Officer, Resources & Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W624, Rockville, MD 20850, 240– 276–6132, tushar.deb@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention E:\FR\FM\18NON1.SGM 18NON1

Agencies

[Federal Register Volume 84, Number 222 (Monday, November 18, 2019)]
[Notices]
[Page 63666]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24849]



[[Page 63666]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Amended Notice of Meeting

    Notice is hereby given of a change in the Interagency Pain Research 
Coordinating Committee meeting on November 18, 2019, 08:30 a.m. to 
05:00 p.m., Building 35A, Porter Neuroscience Center, Room 610, 35 
Convent Drive, Bethesda, MD 20892, which was published in the Federal 
Register on October 18, 2019, 84 FR 55974.
    The meeting notice is amended to change the meeting agenda from the 
meeting will include discussions of committee business items including 
information about the NIH HEAL Initiative and an update on the Pain 
Management Best Practices Interagency Task Force to The meeting will 
include discussions of committee business items including the SUPPORT 
act, an update on the NIH HEAL Initiative and pain initiatives outside 
of the NIH.
    The meeting is open to the public.

    Dated: November 12, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-24849 Filed 11-15-19; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.